ImaCor Hemodynamic Management
In This Issue
Transesophageal Echocardiography
Healthcare Economics and Improved Patient Outcomes in Sepsis
Case Report Miniseries: ImaCor hTEE in Sepsis Patients
Pellerito's Corner
____________________
 
Upcoming
hTEE logo
  Courses
Wagner Lecture...Methodist Houston
Hemodynamic Transesophageal Echo
Workshop

Other hTEE Course Dates:

March 17th Dallas, TX
May 19th  NY, NY
June 30th Chicago, IL

To Register or For More Information,
Please Contact

Geeta Surti
1.516.393.0970 or
courses@imacorinc.com


___________________

Trade Shows

We invite you to join us at the following trade shows: 

    
The Society of Critical Care 
Medicine (SCCM)
February 4-8, 2012
Houston, TX. 
Booth #114.

 
March 20 - 23, 2012
Brussels, Belgium
 
 We look forward to seeing you there!
___________________

Client Testimonial

"Imacor's miniaturized TEE probes provide a visual continuity of care from the O.R. into the ICU, greatly improving patient management" 

Robert Sladen MD
Professor & Vice-Chair of Anesthesiology
College of Physicians & Surgeons
of Columbia University
 
Come Explore the New World of hTEE
____________________

hTEE logo
Video
Sepsis blast  
hTEE for Sepsis Management
 Scott Roth, MD FACC 
Co-Founder & CMO,
ImaCor Inc. 
Watch Now! 
Contact Us

 

imacorinc.com 

 

 

 
 
1-516-393-0970 
Introduction
Transesophageal Echocardiography - Guided Hemodynamic Assessment and Management by Harold Hastings PhD, Co-Founder and CTO of ImaCor Inc.  

 

ICU Director, Volume 3 Issue 1 January 2012 pp. 38 - 41. 

Abstract and Excerpt

 

Abstract

Hemodynamic instability (shock) poses a major challenge in intensive care and is associated with increased mortality, morbidity, length of stay and costs. The purpose of hemodynamic assessment and management is to detect the cause of hemodynamic instability in a given patient, provide actionable information for the physician, and thus help guide the management and resolution of hemodynamic instability. Although transesophageal echocardiography (TEE) has been the gold standard for hemodynamic assessment and management in the cardiac operating room, the invasive nature of conventional TEE has limited its use as a management tool in intensive care. Instead one has seen a variety of indirect hemodynamic monitors used, despite now well-understood limitations as described in a previous Critical Conversation in the July 2011 issue of this journal. Here we describe the use of TEE in intensive care as well as a new TEE system (the ImaCor hTEE system, ImaCor, Garden City, NY) with a miniaturized (approximately nasogastric tube-sized), indwelling probe designed specifically for TEE-guided hemodynamic assessment and management in intensive care (hemodynamic TEE).                                                             Read More

Ecnomics Update

Healthcare Economics and Improved Patient Outcomes in Sepsis (Third in a Series)

  

The cost of caring for sepsis patients is extraordinarily high and directly linked to hemodynamic instability. Conventional hemodynamic management tools do not provide the information required for quality decision-making regarding fluid management, and do not effectively indicate responsiveness to fluid intervention. Indirect monitoring devices are inadequate to effectively assess and manage septic cardiomyopathy and its associated LV/RV dysfunction.1  

 

A published 343,000-patient healthcare economic study indicates that patients' whose length of stay (LOS) is greater than three days use a disproportionate share of patient care resources.2 Improving outcomes for complex patients (i.e sepsis candidates) could result in substantial improvement of the critical care units' bottom line.

 

Kramer Zimmerman economic study 

Read More 

Featured Clinical Case

Case Report Miniseries: Hemodynamic Management of Septic Patients with the ImaCor hTEE™ System

Donald Reiff MD and S. Chris Bellot MD University of Alabama at Birmingham, Birmingham, AL

James Myktenko MD and Chad Wagner MD Vanderbilt University, Nashville, TN

 

Case I. hTEE detects underfilling, rules out LV dysfunction. Donald Reiff MD and S. Chris Bellot MD University of Alabama at Birmingham, Birmingham, AL . . .     
Case II.  hTEE detects RV dysfunction, helps guide pressor weaning in a septic patient. James Myktenko MD and Chad Wagner MD Vanderbilt University, Nashville TN 

                                                                          Read More   



As many of you may be aware, clinical education is one of ImaCor's key imperatives for the year.  With that I am pleased to announce the introduction of Mastering hTEE, the clinical training pathway for physicians and clinicians.  Mastering hTEE is a robust, 5-step program that combines focused, hands-on training, hTEE case reviews and ongoing image assessments to help build the knowledge and skills to effectively administer hTEE to patients. 

 

The response to the Mastering hTEE program has been excellent.  Nicholas Cavarocchi MD, Director of the Surgical Care Unit at Thomas Jefferson University Hospital shared the following sentiments about our 3-view approach:

 

"The new point-of-care device ImaCor hTee probe has evolved into the standard of care in the CTICU setting. Standardized views to evaluate the pericardial space, LV and RV function, and fluid responsiveness allow the intensivist to manage patients' s/p OHS, transplantation, VAD or ECMO support. We have found that the real-time information obtained at any time has allowed us to avoid unnecessary OR take-backs, visualize placement of cannula and weaning for ECMO, adjust VAD flows, and manage right and left ventricular failure."

 

We look forward to implementing this educational program at all of our current and future hTEE customer sites.

On the publishing front I am pleased to announce that just yesterday an article entitled, Initial Experience with a Disposable Transesophageal Echocardiography Monitoring System during Therapeutic Hypothermia following out of Hospital Cardiac Arrest, was published in the The Internet Journal of Emergency and Intensive Care Medicine. The article was authored by a team of physicians at Vanderbilt University Medical Center, including Julian Bick MD, John McPherson MD, Jacob Schaff MD, and Chad Wagner MD.     

Our own Harold Hastings PhD was also published this month in ICU Director.  An abstract and excerpt are included in this month's newsletter.

ImaCor recently exhibited at the 25th Annual Scientfic Assembly of the Eastern Association for the Surgery of Trauma (EAST).  This was our first demonstration of our Zura system and ClariTEE probe at a trauma academic meeting, and we were pleased with the strong reception to the clinical utility of hTEE.  This is a response we are encountering daily, and is echoed by our lead champions caring for patients following severe trauma and burns.  Donald Reiff MD, Director of the Trauma Burn Intensive Care Unit at UAB at Birmingham, recently noted that their use of the Swan-Ganz catheter has been significantly reduced in exchange for hTEE in little less than a year's time.  hTEE is now used in their unit protocol for the care of patients experiencing shock, sepsis, or episodic and sustained hypotension.

I would also like to highlight our next training course, scheduled for February 25th, 2012 in Atlanta, GA.  This is the first in a series of hTEE courses slated for 2012.  Please visit our website for more information or to register.

Finally, Scott Roth MD and I returned from a trip to Switzerland where we participated in several hTEE clinical cases.  We welcome Bern University Hospital as a new installation. 

We look forward to seeing many of you at the Society for Critical Care Medicine (SCCM) show in Houston next week.

With warmest regards,

Peter Pellerito
President & CEO 
Like us on FacebookView our profile on LinkedInFollow us on Twitter